hotspot -WSS

hotspot

author：knowledge 2025-09-27 22:05:48 - browse：8

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Failure, not just success, should guide future doctors

focus

hotspot

WSS

Many breast cancer patients receive more radiation than needed

Vertex Pharmaceuticals may move headquarters in Boston

States should stop sabotaging methadone treatment reform

'Brian's Song' at 50 still offers lessons about cancer for today

Pennsylvania man bitten on the head by bear during attack in his garage

Patient advocates debate FDA's accelerated approval process

entertainment

hotspot

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Trump used to be more articulate. What could explain the change?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Patient advocates debate FDA's accelerated approval process

After affirmative action ruling, medical educators look to 'holistic review'

Food as medicine: Medically tailored meals may get standardized

Hepatitis C has a cure — but many Americans still lack access to it

The Readout: Lenmeldy, GLP

In age of alternative facts, a scholarly course on calling out crap

FDA's naming rule on biosimilars has undermined competition

Wikipedia

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Feed a cold, starve a fever? Here’s what science says

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Doctors push to include dialysis machines in emergency stockpile

Food as medicine: Medically tailored meals may get standardized

entertainment

focus

hotspot

focus